We identified mutations that seem to be heterozygous and clonal as they show allele frequencies of >40 % in the WES and 46–53 % in the validation experiments (NOTCH2, SMYD1, MYD88), with the proximity to 50 % providing an indirect evidence for high tumor cell purity. The gene discussed is SMYD1; the disease is neoplasm.